Literature DB >> 19056842

The cabergoline-resistant prolactinoma patient: new challenges.

Mark E Molitch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19056842     DOI： 10.1210/jc.2008-2244

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  6 in total

1.  Pituitary tumors: cabergoline versus bromocriptine: a meta-analysis?

Authors:  Mark E Molitch
Journal:  Nat Rev Endocrinol       Date:  2011-05       Impact factor: 43.330

2.  Pituitary tumors.

Authors:  Nestoras Mathioudakis; Roberto Salvatori
Journal:  Curr Treat Options Neurol       Date:  2009-07       Impact factor: 3.598

3.  Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor.

Authors:  Daniela Betiana Radl; Jimena Ferraris; Valeria Boti; Adriana Seilicovich; Dipak Kumar Sarkar; Daniel Pisera
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

4.  Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists.

Authors:  Muriel Babey; Rahel Sahli; Istvan Vajtai; Robert H Andres; Rolf W Seiler
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

5.  Pharmacoeconomic aspects of the treatment of pituitary gland tumours.

Authors:  Jerzy Sowiński; Nadia Sawicka; Katarzyna Piątek; Ariadna Zybek; Marek Ruchała
Journal:  Contemp Oncol (Pozn)       Date:  2013-04-29

6.  Current Challenges in the Management of Prolactinomas.

Authors:  Dominique Maiter
Journal:  Eur Endocrinol       Date:  2015-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.